Cargando…

Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination

The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion,...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hojoon, Verma, Pritha, Hong, Kai, Yu, Jin-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289870/
https://www.ncbi.nlm.nih.gov/pubmed/29892027
http://dx.doi.org/10.1038/s41557-018-0048-1
_version_ 1783379990097690624
author Park, Hojoon
Verma, Pritha
Hong, Kai
Yu, Jin-Quan
author_facet Park, Hojoon
Verma, Pritha
Hong, Kai
Yu, Jin-Quan
author_sort Park, Hojoon
collection PubMed
description The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion, as well as the sluggish reductive elimination involving Pd–F bonds. Here, we report the development of a Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination using a chiral transient directing group strategy. In this work, a bulky, amino amide transient directing group was developed to control the stereochemistry of C–H insertion step and selectively promote C(sp(3))–F reductive elimination pathway from Pd(IV)–F intermediate. Stereochemical analysis revealed that while the desired C(sp(3))–F formation proceeds via an inner-sphere pathway with retention of configuration, the undesired C(sp(3))–O formation occurs through an S(N)2-type mechanism. The elucidation of the dual mechanism allows us to rationalize the profound ligand effect on controlling reductive elimination selectivity from high-valent Pd species.
format Online
Article
Text
id pubmed-6289870
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62898702018-12-12 Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination Park, Hojoon Verma, Pritha Hong, Kai Yu, Jin-Quan Nat Chem Article The development of a Pd(II)-catalyzed enantioselective fluorination of C(sp(3))–H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp(3))–H bonds through Pd(II)-insertion, as well as the sluggish reductive elimination involving Pd–F bonds. Here, we report the development of a Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination using a chiral transient directing group strategy. In this work, a bulky, amino amide transient directing group was developed to control the stereochemistry of C–H insertion step and selectively promote C(sp(3))–F reductive elimination pathway from Pd(IV)–F intermediate. Stereochemical analysis revealed that while the desired C(sp(3))–F formation proceeds via an inner-sphere pathway with retention of configuration, the undesired C(sp(3))–O formation occurs through an S(N)2-type mechanism. The elucidation of the dual mechanism allows us to rationalize the profound ligand effect on controlling reductive elimination selectivity from high-valent Pd species. 2018-06-11 2018-07 /pmc/articles/PMC6289870/ /pubmed/29892027 http://dx.doi.org/10.1038/s41557-018-0048-1 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms Reprints and permissions information is available at www.nature.com/reprints.
spellingShingle Article
Park, Hojoon
Verma, Pritha
Hong, Kai
Yu, Jin-Quan
Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title_full Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title_fullStr Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title_full_unstemmed Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title_short Controlling Pd(IV) reductive-elimination pathways enables Pd(II)-catalyzed enantioselective C(sp(3))–H fluorination
title_sort controlling pd(iv) reductive-elimination pathways enables pd(ii)-catalyzed enantioselective c(sp(3))–h fluorination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289870/
https://www.ncbi.nlm.nih.gov/pubmed/29892027
http://dx.doi.org/10.1038/s41557-018-0048-1
work_keys_str_mv AT parkhojoon controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination
AT vermapritha controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination
AT hongkai controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination
AT yujinquan controllingpdivreductiveeliminationpathwaysenablespdiicatalyzedenantioselectivecsp3hfluorination